Global Acute Myeloid Leukemia Therapeutics Market 2015-2019 - New Market Research Report

Acute myeloid leukemia, also known as acute myelogenous leukemia, is a hematopoietic disorder that starts either in hematopoietic stem cells or lineage-specific progenitor cells. Neoplasms arise from bone marrow, however, it spreads quickly into the blood. In the later stages of the disorder, it spreads to spleen, lymph node, liver, brain, spinal cord and testicles. Clonal expansion of the myeloid blasts and the loss of normal hematopoiesis are the main characteristic of acute myeloid leukemia. The disease affects the elderly people with age of 67 years. Fever, pallor, fatigue and hemorrhages are some of the clinical symptoms of the disease. Smoking, exposure to certain chemicals such as benzene, exposure to radiations, cancer patients, who are treated with chemotherapy, blood disorder or genetic mutations are some of the risk factors for the development of acute myeloid leukemia in patients.

Full Report Details at
- http://www.fastmr.com/prod/941855_global_acute_myeloid_leukemia_therapeutics_market.aspx?afid=301

TechNavio's analysts forecast the Global Acute Myeloid Leukemia Therapeutics market to grow at a CAGR of 19.75 percent over the period 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Acute Myeloid Leukemia Therapeutics market for the period 2015-2019. To calculate the market size, the report considers the revenue generated from the sales of various generic, off-label and branded therapies used for treatment.

The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the Global Acute Myeloid Leukemia Therapeutics market. In addition, the report discusses the major drivers that influence the growth of the market and also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.

TechNavio's report, Global Acute Myeloid Leukemia Therapeutics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, the APAC regions and the EMEA regions; it also covers the market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

* Americas
* APAC
* EMEA

Key Vendors

* Bristol Myers Squibb
* Celgene
* Johnson & Johnson
* Pfizer

Other Prominent Vendors

* Abbott
* Ambit BioSciences
* Amgen
* Astex Pharmaceuticals
* AstraZeneca
* Baxter Healthcare
* Bayer
* Boehringer Ingelheim
* Celator Pharmaceuticals
* Chroma Therapeutics
* Chugai Pharmaceutical
* CTI Biopharma
* Cyclacel Pharmaceuticals
* Eisai
* F. Hoffmann-La Roche
* Immune Pharmaceuticals
* Innate Pharma
* Kanisa Pharmaceuticals
* Meda
* Merck Sharp & Dohme
* Midas Pharmaceuticals

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

You may also be interested in these related reports:

- Refractory Acute Myeloid Leukemia Global Clinical Trials Review, H1, 2014
- Acute Myeloid Leukemia Therapeutics Market to 2020 - Novel Therapies to Offer Clinical Benefit in Small Patient Cohorts
- Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2014
- Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2014
- Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2014